At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
Brief supportive-expressive group therapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter Trial of Group Therapy for Breast Cancer
In Brief
A Phase 3 clinical trial evaluating Brief supportive-expressive group therapy for Breast Cancer. Completed, across 10 sites.
Detailed Summary
The purpose of this study is to determine whether women with primary breast cancer who were randomly assigned to receive a brief group therapy would show a greater reduction in mood disturbance over time compared to those randomized to the control condition. We also hypothesized that women who were highly distressed at baseline would show the greatest benefit from participating in a support group, and that therapists with more training and experience would be most effective in reducing distress.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Cummings Foundation
Timeline
Phase 3CompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 1993
Study CompletionJun 1998
First PostedSep 2005
TodayJul 2026
First PostedSep 22, 2005
Enrollment StartJun 1, 1993
Study CompletionJun 1, 1998
TodayJul 2, 2026
Posted 20.8 years ago
Interventions
Brief supportive-expressive group therapybehavioral